These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9824875)

  • 1. Clozapine effects on force control in schizophrenic patients.
    Vrtunski PB; Konicki PE; Jaskiw GE; Brescan DW; Kwon KY; Jurjus G
    Schizophr Res; 1998 Nov; 34(1-2):39-48. PubMed ID: 9824875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of clozapine on motor function in schizophrenic patients.
    Vrtunski PB; Konicki PE; Kwon KY; Jurjus G; Jaskiw GE
    Schizophr Res; 1996 May; 20(1-2):187-98. PubMed ID: 8794509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine-induced myoclonus and generalized seizures.
    Sajatovic M; Meltzer HY
    Biol Psychiatry; 1996 Mar; 39(5):367-70. PubMed ID: 8704069
    [No Abstract]   [Full Text] [Related]  

  • 4. Clozapine-induced stuttering, facial tics and myoclonic seizures: a case report.
    Begum M
    Aust N Z J Psychiatry; 2005 Mar; 39(3):202. PubMed ID: 15701074
    [No Abstract]   [Full Text] [Related]  

  • 5. Myoclonic epileptic seizures during clozapine treatment: a report of three cases.
    Gouzoulis E; Grunze H; von Bardeleben U
    Eur Arch Psychiatry Clin Neurosci; 1991; 240(6):370-2. PubMed ID: 1831670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucocytosis in clozapine-treated patients as predictor of loss of treatment response?
    Prisco V; Iannaccone T; Volpe U; Fabrazzo M
    BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26032702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic drug effects on motor activation measured by functional magnetic resonance imaging in schizophrenic patients.
    Braus DF; Ende G; Weber-Fahr W; Sartorius A; Krier A; Hubrich-Ungureanu P; Ruf M; Stuck S; Henn FA
    Schizophr Res; 1999 Aug; 39(1):19-29. PubMed ID: 10480664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical picture and long-term course of epileptic seizures that occur during clozapine treatment.
    Liukkonen J; Koponen HJ; Nousiainen U
    Psychiatry Res; 1992 Nov; 44(2):107-12. PubMed ID: 1480676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid dose-dependent effect of clozapine on a schizophrenic patient's lipid profile.
    Chiang HL; Liu CC; Hwang TJ
    J Psychopharmacol; 2009 Jun; 23(4):465-7. PubMed ID: 18562410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myoclonic seizures and "leg folding" phenomena with clozapine therapy: report of two cases.
    Antelo RE; Stanilla JK; Martin-Llonch N
    Biol Psychiatry; 1994 Dec; 36(11):759-62. PubMed ID: 7858072
    [No Abstract]   [Full Text] [Related]  

  • 12. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine].
    Stengler-Wenzke K
    Psychiatr Prax; 1999 May; 26(3):145-6. PubMed ID: 10412713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine induced akathisia: a case report and review of the evidence.
    Grover S; Sahoo S
    Indian J Pharmacol; 2015; 47(2):234-5. PubMed ID: 25878393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome.
    Lieberman JA; Safferman AZ; Pollack S; Szymanski S; Johns C; Howard A; Kronig M; Bookstein P; Kane JM
    Am J Psychiatry; 1994 Dec; 151(12):1744-52. PubMed ID: 7977880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of clozapine and typical neuroleptics on information processing of the central nervous system under clinical conditions in schizophrenic disorders: implications for fitness to drive.
    Grabe HJ; Wolf T; Grätz S; Laux G
    Neuropsychobiology; 1999 Nov; 40(4):196-201. PubMed ID: 10559702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison.
    Kumra S; Kranzler H; Gerbino-Rosen G; Kester HM; De Thomas C; Kafantaris V; Correll CU; Kane JM
    Biol Psychiatry; 2008 Mar; 63(5):524-9. PubMed ID: 17651705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine in patients with chronic schizophrenia: serum level, EEG and memory performance.
    Adler G; Grieshaber S; Faude V; Thebaldi B; Dressing H
    Pharmacopsychiatry; 2002 Sep; 35(5):190-4. PubMed ID: 12237790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kindling with clozapine: behavioral and molecular consequences.
    Stevens JR; Denney D; Szot P
    Epilepsy Res; 1996 Dec; 26(1):295-304. PubMed ID: 8985708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gating of auditory P50 in schizophrenics: unique effects of clozapine.
    Nagamoto HT; Adler LE; Hea RA; Griffith JM; McRae KA; Freedman R
    Biol Psychiatry; 1996 Aug; 40(3):181-8. PubMed ID: 8830951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal from clozapine: the "rebound phenomenon".
    Durst R; Teitelbaum A; Katz G; Knobler HY
    Isr J Psychiatry Relat Sci; 1999; 36(2):122-8. PubMed ID: 10472746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.